Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide

Despite the availability of various treatment protocols, response to therapy in patients with Acute Myeloid Leukemia (AML) remains largely unpredictable. Transcriptomic profiling studies have thus far revealed the presence of molecular subtypes of AML that are not accounted for by standard clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Turk, Seyhan, Turk, Can, Akbar, Muhammad Waqas, Kucukkaraduman, Baris, Isbilen, Murat, Demirkol Canli, Secil, Malkan, Umit Yavuz, Okay, Mufide, Ucar, Gulberk, Sayinalp, Nilgun, Haznedaroglu, Ibrahim Celalettin, Gure, Ali Osmay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688131/
https://www.ncbi.nlm.nih.gov/pubmed/33237942
http://dx.doi.org/10.1371/journal.pone.0242497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688131/
https://www.ncbi.nlm.nih.gov/pubmed/33237942
http://dx.doi.org/10.1371/journal.pone.0242497

Ejemplares similares